- Home
- JCSE vs PHIO Comparison
JCSE vs PHIO Comparison
Compare JCSE & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCSE
- PHIO
- Stock Information
- Founded
- JCSE 1999
- PHIO 2011
- Country
- JCSE Singapore
- PHIO United States
- Employees
- JCSE N/A
- PHIO N/A
- Industry
- JCSE Miscellaneous manufacturing industries
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- JCSE Consumer Discretionary
- PHIO Health Care
- Exchange
- JCSE Nasdaq
- PHIO Nasdaq
- Market Cap
- JCSE 7.6M
- PHIO 8.0M
- IPO Year
- JCSE 2022
- PHIO N/A
- Fundamental
- Price
- JCSE $1.55
- PHIO $1.67
- Analyst Decision
- JCSE
- PHIO Strong Buy
- Analyst Count
- JCSE 0
- PHIO 1
- Target Price
- JCSE N/A
- PHIO $36.00
- AVG Volume (30 Days)
- JCSE 14.9K
- PHIO 981.0K
- Earning Date
- JCSE 10-30-2024
- PHIO 04-01-2025
- Dividend Yield
- JCSE 5.81%
- PHIO N/A
- EPS Growth
- JCSE N/A
- PHIO N/A
- EPS
- JCSE 0.12
- PHIO N/A
- Revenue
- JCSE $14,723,999.00
- PHIO N/A
- Revenue This Year
- JCSE N/A
- PHIO N/A
- Revenue Next Year
- JCSE N/A
- PHIO N/A
- P/E Ratio
- JCSE $12.55
- PHIO N/A
- Revenue Growth
- JCSE N/A
- PHIO N/A
- 52 Week Low
- JCSE $0.64
- PHIO $1.53
- 52 Week High
- JCSE $2.39
- PHIO $10.35
- Technical
- Relative Strength Index (RSI)
- JCSE 53.49
- PHIO 42.10
- Support Level
- JCSE $1.42
- PHIO $1.64
- Resistance Level
- JCSE $1.71
- PHIO $1.88
- Average True Range (ATR)
- JCSE 0.08
- PHIO 0.13
- MACD
- JCSE -0.02
- PHIO -0.02
- Stochastic Oscillator
- JCSE 44.83
- PHIO 5.61
About JCSE JE Cleantech Holdings Limited
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.